Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Chiesi USA, Inc. recalls CUROSURF (poractant alfa)

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility
Products
  • CUROSURF (poractant alfa)
Where it was sold

Nationwide within the United States

Nationwide

Units affected
7,235 vials
About this recall
CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.